José M. Lizcano

8.1k citations

72 papers · 3.8k indexed · 1 hit paper · h-index 28

Molecular Biology top 2%
Cell Biology top 2%
Physiology top 5%
Biochemistry top 0.5%
Surgery top 10%

Co-authors: Dario R. Alessi Mercedes Unzeta Mária Deák Nick Morrice Rachel Toth Jérôme Boudeau Lina Udd Olga Göransson
Topics: Microbial metabolism and enzyme function (24 papers)Biochemical Acid Research Studies (10 papers)Hemoglobin structure and function (10 papers)
Cited by: Biochemistry Aging Molecular Biology
Journals: Journal of Biological Chemistry Angewandte Chemie International Edition Journal of Clinical Oncology
Partner nations: Spain United Kingdom France

In The Last Decade

José M. Lizcano

70 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1

2004 1.1k citations José M. Lizcano, Dario R. Alessi et al. profile →

Peers

Countries citing papers authored by José M. Lizcano

Since Specialization

Citations

This map shows the geographic impact of José M. Lizcano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José M. Lizcano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José M. Lizcano more than expected).

Fields of papers citing papers by José M. Lizcano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José M. Lizcano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José M. Lizcano. The network helps show where José M. Lizcano may publish in the future.

Co-authorship network of co-authors of José M. Lizcano

This figure shows the co-authorship network connecting the top 25 collaborators of José M. Lizcano. A scholar is included among the top collaborators of José M. Lizcano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José M. Lizcano. José M. Lizcano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 2 clinical trial of the proautophagic drug ABTL0812 combined with paclitaxel and carboplatin in first-line patients with advanced squamous non-small cell lung carcinoma. 2023 ·Journal of Clinical Oncology ·Joaquim Bosch‐Barrera,Teresa Morán,Purificación Estévez-García,Paloma Martín-Martorell,Renaud Sabatier,Ernest Nadal,José M. Lizcano,(unknown),Héctor Perez‐Montoyo,Marc Yeste‐Velasco,(unknown),José Alfón	1
2	MA01.06 Phase 2 of Pro-Autophagic Drug ABTL0812 in Combination With First-Line Paclitaxel and Carboplatin in IIIb/IV Squamous NSCLC 2021 ·Journal of Thoracic Oncology ·Joaquim Bosch‐Barrera,Teresa Morán,Purificación Estévez-García,Paloma Martín-Martorell,Renaud Sabatier,Ernest Nadal,(unknown),Elena Garralda,José M. Lizcano,(unknown),Héctor Perez‐Montoyo,Marc Yeste‐Velasco,(unknown),(unknown),José Alfón,Jordi Rodón	1
3	ERK5 Inhibition Induces Autophagy-Mediated Cancer Cell Death by Activating ER Stress 2021 ·Frontiers in Cell and Developmental Biology ·(unknown),(unknown),Guillermo Yoldi,(unknown),Nora Diéguez-Martínez,(unknown),(unknown),José M. Lizcano	17
4	The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy 2020 ·Free Radical Biology and Medicine ·(unknown),Sanjib Guha,Stéphane Fourcade,Janani Parameswaran,Montserrat Ruíz,Ann B. Moser,Agatha Schlüter,Michael P. Murphy,José M. Lizcano,Antonio Miranda–Vizuete,Esther Dalfó,Aurora Pujol	19
5	The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase 2015 ·Clinical Cancer Research ·Tatiana Erazo,Mar Lorente,(unknown),(unknown),Patricia Fernández‐Nogueira,(unknown),Paloma Bragado,Gemma Fuster,María Salazar‐Roa,Jordi Espadaler,Javier Hernández‐Losa,José R. Bayascas,(unknown),Laura Vidal,Pedro Gascón,(unknown),José Alfón,Guillermo Velasco,(unknown),José M. Lizcano	59
6	Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. obatoclax 2011 ·Biochemical Pharmacology ·Margarita Espona‐Fiedler,Vanessa Soto‐Cerrato,(unknown),José M. Lizcano,Vı́ctor Guallar,Roberto Quesada,Tianyan Gao,Ricardo Pérez‐Tomás	61
7	Alternative ERK5 regulation by phosphorylation during the cell cycle 2010 ·Cellular Signalling ·Francisco Iñesta-Vaquera,David G. Campbell,Cathy Tournier,Néstor Gómez,José M. Lizcano,Ana Cuenda	38
8	High‐Content Peptide Microarrays for Deciphering Kinase Specificity and Biology 2004 ·Angewandte Chemie International Edition ·Mike Schutkowski,Ulf Reimer,(unknown),Liying Dong,José M. Lizcano,Dario R. Alessi,Jens Schneider‐Mergener	81
9	Neuregulin Signaling on Glucose Transport in Muscle Cells 2004 ·Journal of Biological Chemistry ·Carles Cantó,(unknown),José M. Lizcano,(unknown),Peter R. Shepherd,Lee G.D. Fryer,David Carling,Joan Bertran,Manuel Palacı́n,António Zorzano,Anna Gumà	55
10	Activation of human lung semicarbazide sensitive amine oxidase by a low molecular weight component present in human plasma 2003 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Esther Dalfó,M. Hernández,José M. Lizcano,Keith F. Tipton,Mercedes Unzeta	14
11	Characterization of semicarbazide-sensitive amine oxidase in human subcutaneous adipocytes and search for novel functions 2003 ·Inflammopharmacology ·Christian Carpéné,Virgile Visentin,Nathalie Morin,D. Prévot,Fatima Smih,Philippe Rouet,(unknown),E. Fontana,José M. Lizcano	8
12	Localization of monoamine oxidase A and B and semicarbazide-sensitive amine oxidase in human peripheral tissues 2003 ·Inflammopharmacology ·David Ramonet,Manuel J. Rodrı́guez,Josep Saura,José M. Lizcano,(unknown),Mercedes Unzeta,(unknown),E. Ellen Billett,Nicole Mahy	16
13	Some properties of semicarbazide-sensitive amine oxidase (SSAO) from human cerebrovascular tissues 2001 ·Inflammation Research ·(unknown),(unknown),José M. Lizcano,Mercedes Unzeta	4
14	Studies on the time-dependent activation of microsomal semicarbazide-sensitive amine oxidase 1998 ·Journal of neural transmission. Supplementum ·José M. Lizcano,Alberto Fernández de Arriba,Keith F. Tipton,Mercedes Unzeta	4
15	Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: biochemical and immunohistological characterization 1998 ·Neurochemistry International ·(unknown),José M. Lizcano,Joana Visa,Mercedes Unzeta	38
16	Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I₂‐imidazoline receptors in rat liver 1997 ·British Journal of Pharmacology ·Andrés Ozaita,Gabriel Olmos,M Assumpció Boronat,José M. Lizcano,Mercedes Unzeta,J.A. García‐Sevilla	76
17	Inhibition of bovine lung semicarbazide-sensitive amine oxidase (SSAO) by some hydrazine derivatives 1996 ·Biochemical Pharmacology ·José M. Lizcano,Alberto Fernández de Arriba,Keith F. Tipton,Mercedes Unzeta	48
18	Several aspects on the amine oxidation by semicarbazide-sensitive amine oxidase (SSAO) from bovine lung 1994 ·PubMed ·José M. Lizcano,Alberto Fernández de Arriba,Geoffrey A. Lyles,Mercedes Unzeta	27
19	Amine oxidase activities in rat breast cancer induced experimentally with 7,12-dimethylbenz(α)anthracene 1991 ·Biochemical Pharmacology ·José M. Lizcano,Eduard Escrich,Teresa Ribalta,(unknown),Mercedes Unzeta	27
20	The oxidation of dopamine by the semicarbazide-sensitive amine oxidase (SSAO) from rat vas deferens 1991 ·Biochemical Pharmacology ·José M. Lizcano,Dolors Balsa,Keith F. Tipton,Mercedes Unzeta	26

About José M. Lizcano

José M. Lizcano is a scholar working on Biochemistry, Cell Biology and Molecular Biology, having authored 72 papers that have together received 3.8k indexed citations. Recurring topics across this work include Microbial metabolism and enzyme function (24 papers), Biochemical Acid Research Studies (10 papers) and Hemoglobin structure and function (10 papers). The work is most often cited by research in Biochemistry (466 citations), Aging (86 citations) and Molecular Biology (2.9k citations). José M. Lizcano has collaborated with scholars based in Spain, United Kingdom and France. Frequent co-authors include Dario R. Alessi, Mercedes Unzeta, Mária Deák, Nick Morrice, Rachel Toth, Jérôme Boudeau, Lina Udd, Olga Göransson, Simon A. Hawley and D. Grahame Hardie. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact